Receive our newsletter – data, insights and analysis delivered to you
  1. Deals Analysis
June 30, 2021

Medical Devices industry deals total $8.1bn globally in May 2021

Total medical devices industry deals worth $8.1bn were announced globally for May 2021, with the $1.36bn acquisition of Vectura Group being the sector’s biggest investment, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 6.8% over the previous month of $7.56bn and a drop of 6.3% when compared with the last 12-month average of $8.61bn.

In terms of number of deals, the sector saw a drop of 10.30% with 148 deals in May 2021 when compared to the last 12-month average of 165 deals.

In value terms, North America led the activity with deals worth $4.61bn in May 2021.

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

Medical Devices industry deals in May 2021: Top deals

The top five deals accounted for 45.4% of the overall value during May 2021.

The combined value of the top five deals stood at $3.67bn, against the overall value of $8.1bn recorded for the month.

The top five medical devices industry deals of May 2021 tracked by GlobalData were:

1) Murano Bidco’s $1.36bn acquisition of Vectura Group

2) The $830m private equity deal with Caris Life Sciences by L.P, Canada Pension Plan Investment Board, ClearBridge Investments, Coatue Management, Columbia Threadneedle Investments, Eaton Vance, Fidelity Management & Research, First Light Asset Management, Highland Capital Management, Millennium Management, Orbimed Advisors, Pura Vida Investments, Rock Springs Capital Management, Silver Lake Management, T Rowe Price Associates, TPG Sixth Street Partners and Tudor Investment

3) Allergan Aesthetics’ $550m acquisition of Soliton

4) The $540m venture financing deal of Noom by Novo Holdings, Oak HC/FT Partners, RRE Ventures, Samsung Ventures Investment, Sequoia Capital Operations, Silver Lake Management and Temasek Holdings (Private)

5) NeoGenomics’ acquisition deal with Inivata for $390m.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU